OTCMKTS:CLPBY

Coloplast A/S (CLPBY) Stock Price, News & Analysis

$12.28
-0.05 (-0.41%)
(As of 05/10/2024 ET)
Today's Range
$12.10
$12.42
50-Day Range
$12.05
$14.30
52-Week Range
$9.90
$14.34
Volume
28,837 shs
Average Volume
77,017 shs
Market Capitalization
N/A
P/E Ratio
37.21
Dividend Yield
N/A
Price Target
N/A
CLPBY stock logo

About Coloplast A/S Stock (OTCMKTS:CLPBY)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

CLPBY Stock Price History

CLPBY Stock News Headlines

Gold Mania
Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).
Coloplast A/S (CLPBY)
Coloplast A/S - Allocation of Share Options
Coloplast A/S - Allocation of Share Options
Coloplast A/S - Interim Financial Report, Q1 2023/24
Gold Mania
Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).
Coloplast A/S ADR
Coloplast A/S goes ex-dividend tomorrow
Coloplast A/S - Notice of Annual General Meeting 2023
Major shareholder notification
CLPBY Coloplast A/S
Short Volatility Alert: Coloplast
See More Headlines
Receive CLPBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/09/2024
Today
5/12/2024
Ex-Dividend for 5/28 Dividend
5/17/2024
Dividend Payable
5/28/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:CLPBY
Previous Symbol
NASDAQ:CLPBY
Fax
N/A
Employees
15,913
Year Founded
1954

Profitability

Net Income
$685.88 million
Pretax Margin
24.59%

Debt

Sales & Book Value

Annual Sales
$3.58 billion
Cash Flow
$0.43 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.09

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Kristian Villumsen (Age 54)
    President & CEO
    Comp: $2.55M
  • Mr. Anders Lonning-Skovgaard (Age 52)
    Executive VP & CFO
    Comp: $1.31M
  • Mr. Allan Rasmussen (Age 57)
    Executive Vice President of Global Operations
    Comp: $1.15M
  • Mr. Nicolai Buhl Andersen (Age 55)
    Executive Vice President of Innovation
    Comp: $1.11M
  • Mr. Paul Marcun (Age 57)
    Executive Vice President of Growth
    Comp: $1.33M
  • Mr. Thomas Barfod (Age 54)
    Senior Controller & Employees Representative Director
    Comp: $65.68k
  • Ellen Bjurgert
    Vice President of Investor Relations
  • Dennis Kaysen
    Director of Corporate Communications
  • Dorthe Ronnau (Age 58)
    Senior Vice President of People & Culture
  • Mr. Alain Morvan
    Senior Vice President of Sales Europe

CLPBY Stock Analysis - Frequently Asked Questions

Should I buy or sell Coloplast A/S stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Coloplast A/S in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CLPBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLPBY, but not buy additional shares or sell existing shares.
View CLPBY analyst ratings
or view top-rated stocks.

How have CLPBY shares performed in 2024?

Coloplast A/S's stock was trading at $11.53 at the beginning of 2024. Since then, CLPBY stock has increased by 6.5% and is now trading at $12.28.
View the best growth stocks for 2024 here
.

Are investors shorting Coloplast A/S?

Coloplast A/S saw a increase in short interest in April. As of April 30th, there was short interest totaling 92,500 shares, an increase of 504.6% from the April 15th total of 15,300 shares. Based on an average daily trading volume, of 189,400 shares, the days-to-cover ratio is currently 0.5 days.
View Coloplast A/S's Short Interest
.

How were Coloplast A/S's earnings last quarter?

Coloplast A/S (OTCMKTS:CLPBY) issued its earnings results on Friday, February, 9th. The company reported $0.08 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.08. The firm had revenue of $953.60 million for the quarter. Coloplast A/S had a net margin of 19.45% and a trailing twelve-month return on equity of 39.14%.

How often does Coloplast A/S pay dividends? What is the dividend yield for Coloplast A/S?

Coloplast A/S announced a dividend on Wednesday, May 8th. Investors of record on Monday, May 20th will be paid a dividend of $0.0463 per share on Tuesday, May 28th. The ex-dividend date of this dividend is Friday, May 17th.
Read our dividend analysis for CLPBY
.

How do I buy shares of Coloplast A/S?

Shares of CLPBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CLPBY) was last updated on 5/12/2024 by MarketBeat.com Staff

From Our Partners